Organon & Co | L'Utile Operativo



Operating Profit Cambiamento Data
Adcock Ingram Holdings ZAR 487.33M 8.25M 2024-12
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Celltrion KRW 242.47B 94.87B 2025-06
Cspc Pharmaceutical CNY 1.79B 940.51M 2025-03
Dianthus Therapeutics USD -34927000 3.01M 2025-06
Divis Laboratories Ltd 6.17B 1.62B 2025-06
Gilead Sciences USD 2.7B 467M 2025-06
Glaxosmithkline GBP 2.44B 1.74B 2025-06
Kangmei Pharma CNY 16.43M 3.34M 2025-06
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 27.37M 95.7M 2025-06
Malin Corporation EUR -1100000 400K 2024-12
Medical Developments International AUD 182K 20.42M 2024-12
Merck USD 6.36B 494M 2025-06
Neuren Pharmaceuticals AUD 176.69M 166.79M 2024-12
Novartis USD 5.46B 2.06B 2025-06
Organigram Holdings CAD -2100000 9.2M 2025-06
Organon & Co USD 326M 225M 2025-06
Pharma Mar EUR 24.11M 27.19M 2025-06
Qiagen NV USD 135.97M 10.81M 2025-06
Sartorius EUR 161.8M 24.4M 2025-06
Sino Biopharmaceutical CNY 1.33B 2.53B 2024-12
Tilray USD -42218000 5.65M 2024-11


Organon & Co L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.